Innovate Corp
NYSE:VATE
Intrinsic Value
INNOVATE Corp. engages in the acquisition and investment of assets. [ Read More ]
The intrinsic value of one
VATE
stock under the Base Case scenario is
8.9369
USD.
Compared to the current market price of 0.7401 USD,
Innovate Corp
is
Undervalued by 92%.
Innovate Corp's market capitalization is 58.6m USD.
VATE stock price is 0.7401 USD.
VATE stock price (0.7401 USD) is 92% less than its Intrinsic Value (8.9369 USD).
VATE. Open DCF Valuation
VATE stock price (0.7401 USD) is 92% less than its Relative Value (8.9369 USD). Open Relative Valuation
VATE.
VATE has positive Free Cash Flow for the last twelve months.
VATE has positive Gross Profit for the last twelve months.
VATE's ROIC (Return on Invested Capital) has increased in the last 3 years from -1% to 4%.
VATE's short-term assets (518m USD) exceed its short-term liabilties (414m USD).
VATE's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 4%.
VATE's Revenue has dropped by 13% over the past 12 months.
VATE's long-term liabilties (1B USD) exceed its long-term assets (1B USD).
VATE's ROE (Return on Equity) for the past 12 months is very high and is equal to 30%.
VATE has positive Operating Income for the last twelve months.
VATE's ROE (Return on Equity) has significantly increased in the last 3 years from 0% to 30%.
VATE has a very low three-year average ROIC (Return on Invested Capital): 1%. The company is not efficient at using invested capital to generate operating income.
VATE's Revenue has been growing by an exceptional 26% per year for the last 3 years.
VATE has negative Net Income for the last twelve months.
VATE has positive Net Debt. This means that the company has more debt (679m USD) than cash and short-term investments (81m USD).
VATE's Altman Z-Score is very low and is equal to 0.88.
VATE has negative three-year average ROE (Return on Equity): -25%. The company is not efficient at transforming stockholders' equity into net income.
VATE's D/E (Debt to Equity) is very low and is equal to -4.56.
VATE doesn't generate enough operating income (29m USD) to safely cover interest payments on its debt (49m USD).
Fundamental Analysis
Innovate Corp
Balance Sheet Decomposition
Innovate Corp
| Current Assets | 517.9m |
| Cash & Short-Term Investments | 80.8m |
| Receivables | 397m |
| Other Current Assets | 40.1m |
| Non-Current Assets | 525.7m |
| Long-Term Investments | 1.8m |
| PP&E | 212.6m |
| Intangibles | 306m |
| Other Non-Current Assets | 5.3m |
| Current Liabilities | 413.8m |
| Accounts Payable | 142.9m |
| Accrued Liabilities | 83.9m |
| Other Current Liabilities | 187m |
| Non-Current Liabilities | 778.9m |
| Long-Term Debt | 679.3m |
| Other Non-Current Liabilities | 99.6m |
Earnings Waterfall
Innovate Corp
|
Revenue
|
1.4B
USD
|
|
Cost of Revenue
|
-1.2B
USD
|
|
Gross Profit
|
216m
USD
|
|
Operating Expenses
|
-186.8m
USD
|
|
Operating Income
|
29.2m
USD
|
|
Other Expenses
|
-66.8m
USD
|
|
Net Income
|
-37.6m
USD
|
Free Cash Flow Analysis
Innovate Corp
VATE Profitability Score
Profitability Due Diligence
Innovate Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
Score
Innovate Corp's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
VATE Solvency Score
Solvency Due Diligence
Innovate Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Score
Innovate Corp's solvency score is 33/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VATE Price Targets Summary
Innovate Corp
Ownership
VATE Insider Trading
Buy and sell transactions by insiders
| Period | Sold | Bought | Net |
|---|---|---|---|
| 3 Months |
|
|
|
| 6 Months |
|
|
|
| 9 Months |
|
|
|
| 12 Months |
|
|
|
Shareholder Return
VATE Price
Innovate Corp
| Average Annual Return | 17.05% |
| Standard Deviation of Annual Returns | 61.38% |
| Max Drawdown | -88% |
| Market Capitalization | 58.6m USD |
| Shares Outstanding | 85 200 000 |
| Percentage of Shares Shorted | 10.73% |
Company Profile
Innovate Corp
Country
Industry
Market Cap
Dividend Yield
Description
INNOVATE Corp. engages in the acquisition and investment of assets. The company is headquartered in New York City, New York and currently employs 3,902 full-time employees. The company went IPO on 2011-06-23. Its Infrastructure segment consists of DBM Global Inc. (DBMG) and its wholly owned subsidiaries. DBMG is an integrated industrial construction, structural steel and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services and also fabricates trusses and girders and specializes in the fabrication and erection of large-diameter water pipe and water storage tanks, as well as three dimensional (3D) building information modeling (BIM) and detailing. The Life Sciences segment is comprised of Pansend Life Sciences, LLC (Pansend). Pansend maintains controlling interests of approximately 80% in Genovel Orthopedics, Inc. (Genovel) and approximately 56% in R2 Technologies, Inc. (R2). The Spectrum segment is comprised of HC2 Broadcasting Holdings Inc. (HC2 Broadcasting) and its subsidiaries.
You don't have any saved screeners yet
